Coronavirus Vaccine Serum Institute Of India
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
"Covovax Available For Everyone Above 12 Years", Tweets Adar Poonawalla
Chief Executive Officer of Pune based Serum Institute of India Adar Poonawalla on Wednesday clarified that the COVID-19 vaccine Covovax is available for everyone above the age of 12 years.
-
Covovax Vaccine Now Available For 12-17 Age Group At Private Centres
Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
With 1.25 Billion Jabs, Adar Poonawalla's Covishield Seeks Full Clearance
Adar Poonawalla's Serum Institute Of India has applied to the country's drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the chief executive said on Friday.
-
Time For Allowing Covid Vaccine Booster Shots Is Now: P Chidambaram
P Chidambaram on Wednesday said the time for allowing Covid vaccine booster shots is now and alleged government was exposing millions of vaccinated Indians to infection in its "mistaken zeal to protect" economic interests of Serum Institute of India.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Drug Regulator Seeks More Data Over Approval For Covishield Booster: Report
An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
"Stress And Anxiety": Adar Poonawalla On Initial Days Of Vaccine Drive
Adar Poonawalla, chief of the Serum Institute of India which manufactures the Covishield vaccine, today admitted to stress and anxiety in the initial days of the vaccination drive. The second wave, he added, was worse.
-
Covid Booster Shot "Early Next Year, But...": Adar Poonawalla to NDTV
Adar Poonawalla, the chief of Serum Institute which is manufacturing Covishield, today said the billionth dose of coronavirus vaccine is a milestone for India and over the next two months, the country will catch up further. There is even a possibili
-
"No Need To Mix 2 Different Vaccines": Serum Institute's Cyrus Poonawalla
Serum Institute of India (SII) chairman Dr Cyrus Poonawalla today said he is not in favour of administering two different coronavirus vaccines for better efficacy.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
"Covovax Available For Everyone Above 12 Years", Tweets Adar Poonawalla
Chief Executive Officer of Pune based Serum Institute of India Adar Poonawalla on Wednesday clarified that the COVID-19 vaccine Covovax is available for everyone above the age of 12 years.
-
Covovax Vaccine Now Available For 12-17 Age Group At Private Centres
Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
With 1.25 Billion Jabs, Adar Poonawalla's Covishield Seeks Full Clearance
Adar Poonawalla's Serum Institute Of India has applied to the country's drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the chief executive said on Friday.
-
Time For Allowing Covid Vaccine Booster Shots Is Now: P Chidambaram
P Chidambaram on Wednesday said the time for allowing Covid vaccine booster shots is now and alleged government was exposing millions of vaccinated Indians to infection in its "mistaken zeal to protect" economic interests of Serum Institute of India.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Drug Regulator Seeks More Data Over Approval For Covishield Booster: Report
An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
"Stress And Anxiety": Adar Poonawalla On Initial Days Of Vaccine Drive
Adar Poonawalla, chief of the Serum Institute of India which manufactures the Covishield vaccine, today admitted to stress and anxiety in the initial days of the vaccination drive. The second wave, he added, was worse.
-
Covid Booster Shot "Early Next Year, But...": Adar Poonawalla to NDTV
Adar Poonawalla, the chief of Serum Institute which is manufacturing Covishield, today said the billionth dose of coronavirus vaccine is a milestone for India and over the next two months, the country will catch up further. There is even a possibili
-
"No Need To Mix 2 Different Vaccines": Serum Institute's Cyrus Poonawalla
Serum Institute of India (SII) chairman Dr Cyrus Poonawalla today said he is not in favour of administering two different coronavirus vaccines for better efficacy.
